Business Context and Reporting Period
Company: Chimera Investment Corporation (CIM)
Filing Type: Form 8-K (Current Report)
Date of Report: August 12, 2024
Reporting Period: Event date of August 12, 2024
The filing reports the entry into a material definitive agreement regarding a new debt offering.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, or margin data. It focuses exclusively on a capital raising event.
- New Debt Issuance: $65 million aggregate principal amount of 9.250% Senior Notes due 2029.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional $9.75 million.
- Closing Date: Scheduled for August 19, 2024.
- Underwriters: Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, UBS Securities LLC, Wells Fargo Securities, LLC, Keefe, Bruyette & Woods, Inc., and Piper Sandler & Co.
Material Changes
The primary material change is the expansion of the Company's debt capital structure through the issuance of the new Senior Notes. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
Management Commentary: The Company entered into an underwriting agreement to sell the Notes pursuant to a registration statement on Form S-3. The Company agreed to customary representations, warranties, and indemnification of underwriters against certain liabilities.
Risks and Contingencies: The closing of the offering is subject to customary closing conditions. The summary of the agreement is qualified in its entirety by reference to the full Underwriting Agreement attached as Exhibit 1.1.
Investor Verification Checklist
- Verify the final closing of the $65 million offering on August 19, 2024.
- Confirm whether the underwriters exercised the $9.75 million over-allotment option.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific covenants and use of proceeds.
- Monitor the impact of the new 9.250% interest rate on the Company's overall cost of debt.